Related Experiment Video
Updated: Apr 9, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
Published on: February 8, 2017
Nanocarrier-enabled antimicrobial peptides: Current progress, delivery strategies, and translational challenges
Bilge Ölçeroğlu1, Alper Filiz2, Şevval Çiçek3
1Institute of Nanotechnology and Biotechnology, Istanbul University-Cerrahpasa, Istanbul 34500, Türkiye; Health Biotechnology Joint Research and Applications Center of Excellence, Istanbul 34220, Türkiye; Department of Biotechnology, Institute of Health Sciences, University of Health Sciences, Istanbul, 34662, Türkiye.
Abstract:
Antimicrobial peptides (AMPs) are notable therapeutic candidates with broad-spectrum activity, yet their clinical application remains limited by enzymatic degradation, poor bioavailability, and potential cytotoxicity. Although new AMPs continue to be discovered, delivery strategies remain fragmented, highlighting the need for a coherent overview to guide future research. This review examined 93 studies published between 2022 and 2025, covering 63 distinct AMPs, and categorized nanocarrier systems into four sections: hydrogels, vesicles, structures with inorganic core, and miscellaneous approaches. These carriers have been consistently shown to enhance stability, safety, and delivery efficiency, with additional benefits in combination therapies. Despite these advances, challenges remain in scalability, long-term safety, and regulatory approval. Nanocarrier systems show strong potential to advance AMPs toward clinical use, with further progress relying on improved design, testing, and delivery strategies.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Bioavailability Enhancement: Drug Permeability Enhancement
Microorganisms in Medicine and Therapeutics
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance

